New Generic Blood Pressure Drug Is Approved to Relieve Shortages

31

The F.D.A. made the product review a priority, citing shortages that occurred in the wake of several recalls of drugs that were found to contain potentially cancer-causing chemicals.https://www.nytimes.com/2019/03/12/health/blood-pressure-drug-valsartan.html